Solid Biosciences stock are up on DMD study news [MarketWatch]
Solid Biosciences Inc. (SLDB)
Last solid biosciences inc. earnings: 8/14 07:25 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.solidbio.com/investor-relations
Company Research
Source: MarketWatch
Solid Biosciences stock are up on DMD study news Shares of Solid Biosciences Inc. SLDB, +4.79% gained 22% in premarket trading on Wednesday after the company said two patients who received doses of its experimental Duchenne muscular dystrophy (DMD) treatment showed that the therapy "has the potential" to benefit them. It also said that an adverse event reported by another patient in a clinical study has been resolved, and Solid is working on addressing the clinical hold placed by the Food and Drug Administration as a result. DMD, a rare disorder that primarily affects male children, has become a focus area for life sciences companies in recent years. On Friday the FDA approved Sarepta Therapeutics' SRPT, -1.70% second Duchenne muscular dystrophy treatment. Solid's stock has fallen 82% year-to-date; the S&P 500 SPX, +0.18% is up 27%.
Show less
Read more
Impact Snapshot
Event Time:
SLDB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SLDB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SLDB alerts
High impacting Solid Biosciences Inc. news events
Weekly update
A roundup of the hottest topics
SLDB
News
- Solid Biosciences to Present at the Jefferies London Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- Solid Biosciences to Present at the Jefferies London Healthcare ConferenceGlobeNewswire
- Solid Biosciences Inc. (NASDAQ: SLDB) had its price target lowered by analysts at JPMorgan Chase & Co. from $15.00 to $12.00. They now have an "overweight" rating on the stock.MarketBeat
- Solid Biosciences Inc. (NASDAQ: SLDB) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $15.00 price target on the stock.MarketBeat
- We're Keeping An Eye On Solid Biosciences' (NASDAQ:SLDB) Cash Burn Rate [Yahoo! Finance]Yahoo! Finance
SLDB
Earnings
- 8/13/24 - Beat
SLDB
Sec Filings
- 11/19/24 - Form 4
- 11/19/24 - Form 4
- 11/14/24 - Form SC
- SLDB's page on the SEC website